SCHEMBL4232105

SCHEMBL4232105

Cc1cc(O)cc2oc(-c3ccc(O)c(O)c3)c(OC3CCCC3)c(=O)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLH Q9Y253 6/20 0.58
KDM4E B2RXH2 3/20 0.58
POLB P06746 2/20 0.58
GAA P10253 2/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 1/20 0.58
MMP1 P03956 1/20 0.58
APEX1 P27695 1/20 0.58
HTT P42858 1/20 0.58
RECQL P46063 1/20 0.58
BLM P54132 1/20 0.58
KMT2A Q03164 1/20 0.58
HSD17B10 Q99714 1/20 0.58
AKR1B1 P15121 5/20 0.55
P4HB P07237 4/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
SLCO2B1 O94956 3/20 0.55
MAOA P21397 3/20 0.55
EPHX2 P34913 3/20 0.55
XDH P47989 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4231485 0.98 POLH (0.58) POLHKDM4EPOLBGAAMAPT
SCHEMBL4227938 0.96 POLH (0.60) POLHKDM4EPOLBGAAMAPT
SCHEMBL10859102 0.89 KDM4E (0.67) POLHKDM4EPOLBGAAMAPT
SCHEMBL23158626 0.88 POLH (0.68) POLHKDM4EPOLBGAAMAPT
SCHEMBL10026580 0.83 POLH (0.82) POLHKDM4EPOLBGAAMAPT
SCHEMBL22548987 0.82 KDM4E (0.63) POLHKDM4EPOLBGAAMAPT
SCHEMBL22548985 0.82 KDM4E (0.60) POLHKDM4EPOLBGAAMAPT
SCHEMBL4226740 0.81 MEN1 (0.60) POLHKDM4EPOLBGAAMAPT
SCHEMBL4226904 0.81 MEN1 (0.60) POLHKDM4EPOLBGAAMAPT
SCHEMBL4230543 0.79 POLH (0.75) POLHKDM4EPOLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090182133-A1 BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS SINGAPORE POLYTECHNIC 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182133-A1 BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS SARS1, MAVS, ACE2 POLH 1988/4885KDM4E 1537/4885POLB 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.